Evidence of recombination within human alpha-papillomavirus
Open Access
- 1 January 2007
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 4 (1) , 33
- https://doi.org/10.1186/1743-422x-4-33
Abstract
Human papillomavirus (HPV) has a causal role in cervical cancer with almost half a million new cases occurring each year. Presence of the carcinogenic HPV is necessary for the development of the invasive carcinoma of the genital tract. Therefore, persistent infection with carcinogenic HPV causes virtually all cervical cancers. Some aspects of the molecular evolution of this virus, as the putative importance of recombination in its evolutionary history, are an opened current question. In addition, recombination could also be a significant issue nowadays since the frequency of co-infection with more than one HPV type is not a rare event and, thus, new recombinant types could be currently being generated.Keywords
This publication has 36 references indexed in Scilit:
- Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialThe Lancet, 2006
- New viral vaccinesVirology, 2006
- Papillomaviruses: different genes have different historiesTrends in Microbiology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Cervical cancer control, priorities and new directionsInternational Journal of Cancer, 2003
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccineJournal of Clinical Virology, 2000
- Sequence variation in the capsid protein genes of human papillomavirus type 16Journal of General Virology, 1994
- Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.Proceedings of the National Academy of Sciences, 1992